Heat shock proteins
Kapranos N., Kominea A.
Department of Pathology Aegion General Hospital
Heat shock proteins (Hsps) are a family of proteins whose function
is to protect the cells from environmental or pathophysiologic
stimuli. Apart from thermal stimuli Hsps are activated by other
causes such as irradiation, heavy metals, toxins and oxidants.
Viral and bacterial infections, ischemia and glucose starvation
also stimulate Hsps' response. Several of the Hsps participate
in the cell cycle and are also involved in different stages of
development and differentiation under the regulation by hormones
and growth factors. Hsps function as molecular chaperones regulating
the correct folding and intracellular translocation of polypeptides
and play a critical role in the maintenance of hormone receptors
in the inactive state. Hsps are classified according to their
molecular weight in six groups: Hsp27, Hsp40, Hsp60, Hsp70, Hsp90
and Hsp100. Some of these proteins are constitutively expressed,
whereas others are induced by stresses depending on the type of
cell and stress stimulus. Hsps' synthesis is regulated by heat
shock transcription factors (HSFs) which act through a higly conserved
upstream response element of the promoter region of Hsp genes
characterized by multiple inverted repeats of AGAAn sequence.
Hsp27 and Hsp70 have been associated with the presence of estrogen
and progesterone receptors in breast carcinomas and they have
been found to have negative prognostic significance in node-negative
breast cancer patients. In human cancer and cell lines it has
been reported that Hsp27 and Hsp70 play an important role to the
resistance in some of the chemotherapeutic drugs. Hsps are also
involved in the immune response in cancer and in the cellular
protective mechanisms in ischemic and imflammatoty conditions.
The functions, the mechanisms of transcriptional regulation
and the clinical significance of Hsps are summarized in this review.
Key words: Heat shock proteins, Hsp, HSF, thermotolerance,
tumor progostic factors, ischemic injury, drug resistance.
|